Arvinas Inc (ARVN) recent activity suggests a positive outlook with the last week’s performance of 7.80%

Arvinas Inc (NASDAQ: ARVN) On Friday, started off the session at the price of On Friday, remained unchanged from the previous trading day, before settling in for the closing price of $35.23. Within the past 52 weeks, ARVN’s price has moved between $13.57 and $53.08.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


A company in the Healthcare sector has jumped its sales by 80.30% annually for the last half of the decade. The company achieved an average annual earnings per share of 39.01%. With a float of $59.40 million, this company’s outstanding shares have now reached $68.00 million.

In an organization with 445 employees, it is important to assess its efficiency.

Arvinas Inc (ARVN) Insider and Institutional Ownership

Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Arvinas Inc is 13.13%, while institutional ownership is 94.93%. The most recent insider transaction that took place on Feb 23 ’24, was worth 244,472. In this transaction President and CEO of this company sold 5,196 shares at a rate of $47.05, taking the stock ownership to the 1,036,681 shares. Before that another transaction happened on Feb 23 ’24, when Company’s Chief Financial Officer sold 1,702 for $47.05, making the entire transaction worth $80,079. This insider now owns 181,916 shares in total.

Arvinas Inc (ARVN) Latest Financial update

As on 3/31/2024, Multinational firm has announced its last quarter scores, in which it reported -1.25 earnings per share (EPS) for the period topping the consensus outlook (set at -1.65) by 0.4. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.07 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 39.01% per share during the next fiscal year.

Arvinas Inc (NASDAQ: ARVN) Trading Performance Indicators

Arvinas Inc (ARVN) is currently performing well based on its current performance indicators. A quick ratio of 4.94 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 33.81.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.93, a number that is poised to hit -1.12 in the next quarter and is forecasted to reach -4.66 in one year’s time.

Technical Analysis of Arvinas Inc (ARVN)

Let’s dig in a bit further. During the last 5-days, its volume was 0.88 million. That was better than the volume of 0.72 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 68.89%. Additionally, its Average True Range was 1.82.

During the past 100 days, Arvinas Inc’s (ARVN) raw stochastic average was set at 19.49%, which indicates a significant decrease from 64.98% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 46.88% in the past 14 days, which was higher than the 46.68% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $35.94, while its 200-day Moving Average is $32.08. However, in the short run, Arvinas Inc’s stock first resistance to watch stands at $35.76. Second resistance stands at $36.29. The third major resistance level sits at $36.81. If the price goes on to break the first support level at $34.71, it is likely to go to the next support level at $34.18. The third support level lies at $33.65 if the price breaches the second support level.

Arvinas Inc (NASDAQ: ARVN) Key Stats

Market capitalization of the company is 2.41 billion based on 68,432K outstanding shares. Right now, sales total 78,500 K and income totals -367,300 K. The company made 25,300 K in profit during its latest quarter, and -69,400 K in sales during its previous quarter.